4basebio PLC (AIM:4BB)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 525.30
-4.70 (-0.89%)
Nov 5, 2026, 1:26 PM GMT
4basebio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, 4basebio stock has a consensus rating of "Strong Buy" and an average price target of 1,130p. The average 1-year stock price forecast is 115.12% higher than the current stock price, while the lowest is 940p (+78.95%) and the highest is 1,450p (+176.03%).
Price Target: 1,130p (+115.12%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 29, 2026.
Analyst Ratings
The average analyst rating for 4basebio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains 1,000p | Buy | Maintains | 1,000p | +90.37% | Sep 29, 2026 |
Financial Forecast
Revenue This Year
994.62K
from 1.69M
Decreased by -41.25%
Revenue Next Year
4.84M
from 994.62K
Increased by 386.57%
EPS This Year
-1.07
from -1.09
EPS Next Year
-0.80
from -1.07
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.